World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
31673
World Ranking
13983
National Ranking
7097

Julio Garcia-Aguilar publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Julio Garcia-Aguilar sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 434 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Julio Garcia-Aguilar D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Julio Garcia-Aguilar sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Julio Garcia-Aguilar is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on colorectal cancer, emphasizing surgical treatments, screening, detection, and genetic factors. The scientist's main fields of study include Medicine, with significant contributions in the subfields of Oncology, Surgery, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, and Radiology, Nuclear Medicine and Imaging.

Their research topics cover several areas including:

  • Colorectal Cancer Surgical Treatments
  • Colorectal and Anal Carcinomas
  • Colorectal Cancer Screening and Detection
  • Genetic factors in colorectal cancer
  • Colorectal Cancer Treatments and Studies
  • Gastric Cancer Management and Outcomes
  • Radiomics and Machine Learning in Medical Imaging

Julio Garcia-Aguilar has contributed to multiple peer-reviewed publications. Some recent papers include:

  • "Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy," 2022, Journal of Clinical Oncology
  • "PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer," 2022, New England Journal of Medicine
  • "Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients," 2022, Cell
  • "Mismatch Repair-Deficient Rectal Cancer and Resistance to Neoadjuvant Chemotherapy," 2020, Clinical Cancer Research
  • "Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial," 2023, Journal of Clinical Oncology

Their publishing record includes frequent appearances in specific journals such as:

  • Journal of Clinical Oncology
  • Annals of Surgical Oncology
  • Diseases of the Colon & Rectum
  • Cancer Research
  • International Journal of Radiation Oncology*Biology*Physics

Julio Garcia-Aguilar has collaborated extensively with a group of frequent co-authors, which include:

  • Martin R. Weiser
  • J. Joshua Smith
  • Philip B. Paty
  • Emmanouil P. Pappou
  • Garrett M. Nash

Best Publications

  • Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

    Monique Maas;Patty J. Nelemans;Vincenzo Valentini;Prajnan Das

  • ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18).

    M S Diamond;D E Staunton;A R de Fougerolles;S A Stacker

  • The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands.

    Michael S. Diamond;Julio Garcia-Aguilar;Joanna K. Bickford;Angel L. Corbi

  • Anal fistula surgery. Factors associated with recurrence and incontinence.

    Julio Garcia-Aguilar;Carlos Belmonte;W. Douglas Wong;Stanley M. Goldberg

  • Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial

    Julio Garcia-Aguilar;Oliver S Chow;David D Smith;Jorge E Marcet

  • Is local excision adequate therapy for early rectal cancer

    Anders Mellgren;Prayuth Sirivongs;David A. Rothenberger;Robert D. Madoff

  • Colon and Rectum

    Carolyn C. Compton;David R. Byrd;Julio Garcia-Aguilar;Scott H. Kurtzman

  • Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.

    Andrea Cercek;Campbell S.D. Roxburgh;Campbell S.D. Roxburgh;Paul Strombom;J. Joshua Smith

  • Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors

    Julio Garcia-Aguilar;Johan Pollack;Suk Hwan Lee;Enrique Hernandez De Anda

  • A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision.

    Julio García-Aguilar;Enrique H. Hernandez de Anda;Prayuth Sirivongs;Suk Hwan Lee

  • Local excision of rectal cancer without adjuvant therapy: a word of caution

    Julio Garcia-Aguilar;Anders F. Mellgren;Prayuth Sirivongs;Donald Buie

  • Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing

    Diana Mandelker;Liying Zhang;Yelena Kemel;Yelena Kemel;Zsofia K. Stadler;Zsofia K. Stadler

  • Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial

    Julio Garcia-Aguilar;Lindsay A Renfro;Oliver S Chow;Qian Shi

  • Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy

    J. Joshua Smith;Paul Strombom;Oliver S. Chow;Campbell S. Roxburgh;Campbell S. Roxburgh

  • Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer

    Atsushi Ogura;Atsushi Ogura;Atsushi Ogura;Tsuyoshi Konishi;Tsuyoshi Konishi;Chris Cunningham;Julio Garcia-Aguilar

  • A rectal cancer organoid platform to study individual responses to chemoradiation.

    Karuna Ganesh;Chao Wu;Kevin P. O’Rourke;Bryan C. Szeglin

  • Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial.

    Julio Garcia-Aguilar;David D. Smith;Karin Avila;Emily K. Bergsland

  • Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management

    J. Joshua Smith;Oliver S. Chow;Marc J. Gollub;Garrett M. Nash

  • A Phase II Trial of Neoadjuvant Chemoradiation and Local Excision for T2N0 Rectal Cancer: Preliminary Results of the ACOSOG Z6041 Trial

    Julio Garcia-Aguilar;Qian Shi;Charles R. Thomas;Emily Chan

  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    Bastien Nguyen;Christopher Fong;Anisha Luthra;Shaleigh A. Smith

Frequent Co-Authors

Martin R. Weiser
Martin R. Weiser Memorial Sloan Kettering Cancer Center
J. Joshua Smith
J. Joshua Smith Memorial Sloan Kettering Cancer Center
Philip B. Paty
Philip B. Paty Memorial Sloan Kettering Cancer Center
Jose G. Guillem
Jose G. Guillem University of North Carolina at Chapel Hill
Jinru Shia
Jinru Shia Memorial Sloan Kettering Cancer Center
Leonard Saltz
Leonard Saltz Memorial Sloan Kettering Cancer Center
Carolyn C. Compton
Carolyn C. Compton Arizona State University
Mithat Gonen
Mithat Gonen Memorial Sloan Kettering Cancer Center
Michael F. Berger
Michael F. Berger Memorial Sloan Kettering Cancer Center
Nancy E. Kemeny
Nancy E. Kemeny Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative or complementary pathways to a traditional medical degree can open a range of opportunities in the healthcare field. Many students are opting for online programs that offer flexibility, affordability, and a quick route to meaningful careers.

For those interested in pharmaceuticals, an online pharmacy school cost can be significantly lower than in-person programs, making it an attractive choice for aspiring pharmacists. Similarly, those heading towards the administrative side of healthcare can pursue him programs online to gain expertise in managing patient data and health records.

Entry-level careers like medical billing and coding also offer remote learning options. A low cost medical coding and billing online program can provide a fast track into the workforce as demand for these skills increases.

For advanced practice, registered nurses may consider the cheapest nurse practitioner programs online, allowing for greater career mobility and leadership roles in patient care.

These online healthcare degrees deliver flexible learning, affordability, and diverse career prospects—ideal for those looking to enter or advance in the medical field.

Best Scientists Citing Julio Garcia-Aguilar

Trending Scientists

Recently Published Articles